Medtronic Acquires Sapiens SBS - Quick Facts

(RTTNews) - Medtronic Inc. (MDT) announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep brain stimulation, or DBS, technologies for approximately $200 million in an all-cash deal. The company said the transaction does not impact its fiscal 2015 earnings guidance.

Sapiens SBS, located in Eindhoven, The Netherlands, is developing a DBS system that features an advanced DBS lead with 40 individual stimulation points. Medtronic and Sapiens SBS will work to finalize product development and begin clinical research to integrate these technologies into an expanded portfolio of DBS products within Medtronic's Neuromodulation business.

Sapiens SBS is a spin-out of Philips, and is backed by Wellington Partners, Edmond de Rothschild Investment Partners, Life Sciences Partners, the Wellcome Trust, INKEF Capital and Gilde Healthcare.